I. A. Коstanyan

658 citations

39 papers · 557 indexed · h-index 12

Co-authors: Vladimir Zamotin Ludmilla A. Morozova‐Roche Anna L. Gharibyan Boris A. Margulis Kiran Yanamandra В. М. Липкин Mantas Mališauskas E. V. Navolotskaya
Topics: Chemical Reactions and Isotopes (10 papers)Alzheimer's disease research and treatments (6 papers)Cell death mechanisms and regulation (4 papers)
Cited by: Pharmaceutical Science Physiology Biological Psychiatry
Journals: Journal of Molecular Biology Biochemistry FEBS Letters
Partner nations: Russia Sweden United Kingdom

In The Last Decade

I. A. Коstanyan

39 papers receiving 547 citations

Peers

Countries citing papers authored by I. A. Коstanyan

Since Specialization

Citations

This map shows the geographic impact of I. A. Коstanyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. A. Коstanyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. A. Коstanyan more than expected).

Fields of papers citing papers by I. A. Коstanyan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. A. Коstanyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. A. Коstanyan. The network helps show where I. A. Коstanyan may publish in the future.

Co-authorship network of co-authors of I. A. Коstanyan

This figure shows the co-authorship network connecting the top 25 collaborators of I. A. Коstanyan. A scholar is included among the top collaborators of I. A. Коstanyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. A. Коstanyan. I. A. Коstanyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MODULATION OF FUNCTIONAL MACROPHAGE ACTIVITY BY HLDF6 PEPTIDE UPON ADDING OPIATE RECEPTOR AGONISTS 2014 ·Medical Immunology (Russia) ·(unknown),(unknown),(unknown),(unknown),I. A. Коstanyan	3
2	Novel protein haponin regulates cellular response to oxidative stress 2011 ·Doklady Biochemistry and Biophysics ·Е. В. Смирнова,Tatiana V. Rakitina,(unknown),(unknown),(unknown),А. В. Липкин,I. A. Коstanyan,В. М. Липкин	7
3	Postischemic administration of HLDF-6 peptide ameliorates cognitive dysfunction and brain damage induced by chronic cerebral Ischemia in rats 2009 ·Doklady Biological Sciences ·I. A. Коstanyan,З. И. Сторожева,(unknown),В. М. Липкин	10
4	Granulocyte differentiation inducer, hexapeptide HLDF-6, decreases cytotoxic effect of tumor necrosis factor on HL-60 cell line 2007 ·Biochemistry (Moscow) ·(unknown),Tatiana V. Rakitina,(unknown),I. A. Коstanyan	1
5	Hemodynamic effects of peptide fragments of differentiation factor HLDF 2006 ·Bulletin of Experimental Biology and Medicine ·(unknown),(unknown),(unknown),(unknown),I. A. Коstanyan	3
6	Experimental model of hemorrhagic stroke: Rabbit immunization with HL-60 promyelocytic cell differentiation factor 2006 ·Bulletin of Experimental Biology and Medicine ·(unknown),(unknown),(unknown),M. A. Gruden,И И Бабиченко,I. A. Коstanyan	3
7	Amyloidogenic properties of the artificial protein albebetin and its biologically active derivatives. The role of electrostatic interactions in fibril formation 2006 ·Biochemistry (Moscow) ·(unknown),Vladimir Zamotin,Mantas Mališauskas,Rita V. Chertkova,I. A. Коstanyan,Д. А. Долгих,М. П. Кирпичников,Ludmilla A. Morozova‐Roche	3
8	Lysozyme Amyloid Oligomers and Fibrils Induce Cellular Death via Different Apoptotic/Necrotic Pathways 2006 ·Journal of Molecular Biology ·Anna L. Gharibyan,Vladimir Zamotin,Kiran Yanamandra,(unknown),Boris A. Margulis,I. A. Коstanyan,Ludmilla A. Morozova‐Roche	183
9	Hexapeptides HLDF-6 and PEDF-6 restore memory in rats after chronic intracerebroventricular treatment with β-amyloid peptide Aβ(25–35) 2006 ·Bulletin of Experimental Biology and Medicine ·З. И. Сторожева,A. T. Proshin,Sergey S. Zhokhov,В. В. Шерстнев,(unknown),В. М. Липкин,I. A. Коstanyan	6
10	Cytotoxicity of albebetin oligomers depends on cross‐β‐sheet formation 2006 ·FEBS Letters ·Vladimir Zamotin,Anna L. Gharibyan,(unknown),(unknown),Д. А. Долгих,М. П. Кирпичников,I. A. Коstanyan,Ludmilla A. Morozova‐Roche	17
11	Different Mechanisms of Protective and Differentiative Activities of Homological Peptides TGENHR and TQVEHR 2004 ·Biochemistry (Moscow) ·Sergey S. Zhokhov,I. A. Коstanyan,(unknown),(unknown),(unknown),З. И. Сторожева,A. T. Proshin,И И Бабиченко,В. М. Липкин	7
12	Autoimmune Responses to Amyloid Structures of Aβ<sub>(25–35)</sub> Peptide and Human Lysozyme in the Serum of Patients with Progressive Alzheimer’s Disease 2004 ·Dementia and Geriatric Cognitive Disorders ·M. A. Gruden,(unknown),Mantas Mališauskas,Vladimir Zamotin,Robert D. E. Sewell,N. I. Voskresenskaya,I. A. Коstanyan,(unknown),Ludmilla A. Morozova‐Roche	57
13	HLDF-6 peptide affects behavioral reactions and organism functions dependent on androgen hormones in normal and castrated male mice 2004 ·Regulatory Peptides ·(unknown),Sergey S. Zhokhov,И И Бабиченко,(unknown),(unknown),А. А. Байжуманов,(unknown),В. М. Липкин,I. A. Коstanyan	11
14	The Precursor of Differentiation Factor HLDF and Ribosomal Protein RPS21 Have a Common N-Terminal Sequence 2004 ·Russian Journal of Bioorganic Chemistry ·Е. В. Смирнова,(unknown),Tatiana V. Rakitina,(unknown),(unknown),(unknown),И И Бабиченко,I. A. Коstanyan,(unknown)	2
15	An Artificial Protein with the Biological Activity of the Differentiation Factor for the HL-60 Cell Line of Human Promyelocyte Leukemia 2003 ·Russian Journal of Bioorganic Chemistry ·Rita V. Chertkova,I. A. Коstanyan,(unknown),(unknown),Д. А. Долгих,М. П. Кирпичников	2
16	Soluble Fas Antigen in the Serum of Patients with Colon Cancer 2001 ·Bulletin of Experimental Biology and Medicine ·Н. Е. Кушлинский,(unknown),(unknown),(unknown),(unknown),I. A. Коstanyan,В И Кныш,В. М. Липкин	23
17	The structural and functional homology between PEDF and HLDF. The regulatory role of serpin loop in PEDF function 2000 ·European Journal of Neuroscience ·I. A. Коstanyan,(unknown),(unknown),(unknown),В. М. Липкин,Igor I. Baskin,(unknown),Joyce Tombran‐Tink	1
18	Influence of l-glutamic acid on binding of interleukin-1β, tumour necrosis factor-α and interleukin-6 to HL-60 cells 1998 ·Immunology Letters ·I. A. Коstanyan,(unknown),E. V. Navolotskaya,(unknown),(unknown),(unknown),V.P. Zav′yalov,Valery M. Lipkin	2
19	Study of interaction between l-glutamate and human blood lymphocytes 1997 ·Immunology Letters ·I. A. Коstanyan,(unknown),E. V. Navolotskaya,(unknown)	31
20	A new human leukemia cell 8.2 kDa differentiation factor: Isolation and primary structure 1994 ·FEBS Letters ·I. A. Коstanyan,(unknown),(unknown),(unknown),Valery M. Lipkin	23

About I. A. Коstanyan

I. A. Коstanyan is a scholar working on Pharmaceutical Science, Physiology and Biological Psychiatry, having authored 39 papers that have together received 557 indexed citations. Recurring topics across this work include Chemical Reactions and Isotopes (10 papers), Alzheimer's disease research and treatments (6 papers) and Cell death mechanisms and regulation (4 papers). The work is most often cited by research in Pharmaceutical Science (81 citations), Physiology (280 citations) and Biological Psychiatry (20 citations). I. A. Коstanyan has collaborated with scholars based in Russia, Sweden and United Kingdom. Frequent co-authors include Vladimir Zamotin, Ludmilla A. Morozova‐Roche, Anna L. Gharibyan, Boris A. Margulis, Kiran Yanamandra, В. М. Липкин, Mantas Mališauskas, E. V. Navolotskaya, Robert D. E. Sewell and M. A. Gruden. Their work appears in journals such as Journal of Molecular Biology, Biochemistry and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact